(Q44301961)

English

A randomised, double blind, placebo controlled crossover study of the cholecystokinin 2 antagonist L-365,260 as an adjunct to strong opioids in chronic human neuropathic pain

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

A randomised, double blind, placebo controlled crossover study of the cholecystokinin 2 antagonist L-365,260 as an adjunct to strong opioids in chronic human neuropathic pain (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

neuropathic pain

0 references

0 references

chronic neuropathic pain

0 references

cholecystokinin

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Gary J McCleane

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

0 references

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Neuroscience Letters

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

338

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

151-154

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Increases of CCK mRNA and peptide in different brain areas following acute and chronic administration of morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901388-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901388-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901388-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Autoradiographical detection of cholecystokinin-A receptors in primate brain using 125I-Bolton Hunter CCK-8 and 3H-MK-329.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901388-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901388-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The CCK-A and CCK-B receptor antagonists, devazepide and L-365,260, enhance morphine antinociception only in non-acclimated rats exposed to a novel environment

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901388-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase 1 study of the cholecystokinin (CCK) B antagonist L-365,260 in human subjects taking morphine for intractable non-cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901388-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Involvement of different subtypes of cholecystokinin receptors in opioid antinociception in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901388-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Proglumide prevents and curtails acute tolerance to morphine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901388-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901388-5

7 January 2021

based on heuristic

inferred from DOI database lookup

PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901388-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901388-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Marked increase in cholecystokinin B receptor messenger RNA levels in rat dorsal root ganglia after peripheral axotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901388-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0304-3940(02)01388-5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44301961&oldid=2109292181"